(pressebox) Ennigerloh, 27.04.2009, As one of the leading European contract manufacturer and packager for solid dosage forms, Rottendorf expands its activities within the contract development sector. Certified by GMP and FDA, the company meets national as well as international market requirements and already offers, as experienced service provider, the complete range of contract development services: development of formulations and processes as well as validation, manufacturing of clinical batches, optimization and updating of files, etc.
From May 2009, Rottendorf now presents its new pilot plant, a development and upscaling center representing all common production technologies for solids but offering as well innovative technologies. This investment enables Rottendorf to extend the existing service package and to underline its position as qualified contract developer.Über Rottendorf Pharma GmbH
Rottendorf Pharma is one of the leading pharmaceutical contract manufacturers for development, production and packaging of solid dosage forms. Besides the two sites in Germany the company is also represented by a subsidiary, Rottendorf Pharma S.A.S., in Valenciennes/France.
Rottendorf Pharma belongs to a non-profit foundation and focuses not only on market success but also on social engagement.
For its 150 customers, among them a lot of the biggest Big Pharma companies, Rottendorf is an exclusive service provider who offers a maximum of production reliability and investment security in addition to modern production facilities and high potency technologies. Audited and approved by the internationally recognized FDA, the company is not only qualified for the European but also for the US market. Moreover, Rottendorf is optimally positioned for future challenges due to annual investments of several million Euros in the modernization and expansion of the facilities and technologies. In addition to contract manufacturing and contract packaging, the development of processes and formulations plays a decisive role in the future company strategy.
Further information is available on the internet at www.rottendorf-pharma.de